Q9JI57
Gene name |
Gtf2ird1 (Ben) |
Protein name |
General transcription factor II-I repeat domain-containing protein 1 |
Names |
GTF2I repeat domain-containing protein 1, Binding factor for early enhancer |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:57080 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q9JI57
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q9JI57-F1 | Predicted | AlphaFoldDB |
59 variants for Q9JI57
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs3388795802 | 6 | K>E | No | EVA | |
| rs3388788194 | 83 | D>N | No | EVA | |
| rs3388798491 | 94 | N>S | No | EVA | |
| rs3388798679 | 122 | C>* | No | EVA | |
| rs3388788132 | 129 | Q>K | No | EVA | |
| rs3388778849 | 210 | D>E | No | EVA | |
| rs3388798184 | 236 | A>G | No | EVA | |
| rs3388798122 | 236 | A>T | No | EVA | |
| rs3388798666 | 250 | P>L | No | EVA | |
| rs3388804442 | 274 | V>M | No | EVA | |
| rs3388800834 | 283 | D>H | No | EVA | |
| rs3388791822 | 294 | H>Y | No | EVA | |
| rs3388778847 | 307 | Q>* | No | EVA | |
| rs3388786394 | 318 | Q>K | No | EVA | |
| rs3388788168 | 329 | S>P | No | EVA | |
| rs3388793126 | 357 | I>F | No | EVA | |
| rs3388798635 | 385 | E>* | No | EVA | |
| rs3388804360 | 428 | D>VSDG* | No | EVA | |
| rs3388796532 | 440 | D>Y | No | EVA | |
| rs3388788115 | 445 | E>D | No | EVA | |
| rs3388798200 | 446 | P>S | No | EVA | |
| rs3388800892 | 467 | G>V | No | EVA | |
| rs3388796881 | 469 | A>V | No | EVA | |
| rs3388804389 | 478 | E>D | No | EVA | |
| rs3388790624 | 498 | P>VSDG* | No | EVA | |
| rs3388793163 | 502 | D>G | No | EVA | |
| rs3388786405 | 552 | R>W | No | EVA | |
| rs3388782557 | 604 | L>V | No | EVA | |
| rs3388796512 | 618 | F>S | No | EVA | |
| rs3388791759 | 624 | R>E* | No | EVA | |
| rs3388786260 | 625 | K>R | No | EVA | |
| rs3388795880 | 628 | E>G | No | EVA | |
| rs3396202162 | 705 | A>P | No | EVA | |
| rs3396087862 | 709 | K>* | No | EVA | |
| rs3396002787 | 709 | K>R | No | EVA | |
| rs3396002792 | 710 | Y>C | No | EVA | |
| rs3388790662 | 712 | V>A | No | EVA | |
| rs3388790662 | 712 | V>E | No | EVA | |
| rs3388800841 | 712 | V>L | No | EVA | |
| rs3388800816 | 720 | K>Q | No | EVA | |
| rs3388796911 | 741 | C>Y | No | EVA | |
| rs3388788189 | 743 | F>L | No | EVA | |
| rs3388791755 | 754 | V>M | No | EVA | |
| rs3388796870 | 757 | K>R | No | EVA | |
| rs3388796476 | 805 | A>T | No | EVA | |
| rs3388796497 | 809 | G>W | No | EVA | |
| rs3388784595 | 824 | E>D | No | EVA | |
| rs3388782576 | 824 | E>K | No | EVA | |
| rs3388768445 | 839 | P>L | No | EVA | |
| rs3388795811 | 878 | A>D | No | EVA | |
| rs3388796502 | 920 | Q>E | No | EVA | |
| rs3388768438 | 922 | K>SDG* | No | EVA | |
| rs3388782505 | 924 | L>F | No | EVA | |
| rs3388778907 | 973 | H>Q | No | EVA | |
| rs3388796536 | 998 | D>N | No | EVA | |
| rs3388765667 | 1013 | K>M | No | EVA | |
| rs3388790646 | 1082 | H>P | No | EVA | |
| rs3388765632 | 1083 | W>R | No | EVA | |
| rs3388804354 | 1086 | R>K | No | EVA |
No associated diseases with Q9JI57
6 regional properties for Q9JI57
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| repeat | GTF2I-like repeat | 119 - 213 | IPR004212-1 |
| repeat | GTF2I-like repeat | 342 - 436 | IPR004212-2 |
| repeat | GTF2I-like repeat | 556 - 650 | IPR004212-3 |
| repeat | GTF2I-like repeat | 681 - 775 | IPR004212-4 |
| repeat | GTF2I-like repeat | 805 - 899 | IPR004212-5 |
| repeat | GTF2I-like repeat | 908 - 1002 | IPR004212-6 |
3 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| nucleoplasm | That part of the nuclear content other than the chromosomes or the nucleolus. |
| nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
3 GO annotations of molecular function
| Name | Definition |
|---|---|
| DNA-binding transcription factor activity | A transcription regulator activity that modulates transcription of gene sets via selective and non-covalent binding to a specific double-stranded genomic DNA sequence (sometimes referred to as a motif) within a cis-regulatory region. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units, and include bacterial operons. |
| DNA-binding transcription repressor activity, RNA polymerase II-specific | A DNA-binding transcription factor activity that represses or decreases the transcription of specific gene sets transcribed by RNA polymerase II. |
| RNA polymerase II cis-regulatory region sequence-specific DNA binding | Binding to a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in cis relative to the transcription start site (i.e., on the same strand of DNA) of a gene transcribed by RNA polymerase II. |
3 GO annotations of biological process
| Name | Definition |
|---|---|
| negative regulation of transcription by RNA polymerase II | Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II. |
| transcription by RNA polymerase II | The synthesis of RNA from a DNA template by RNA polymerase II (RNAP II), originating at an RNA polymerase II promoter. Includes transcription of messenger RNA (mRNA) and certain small nuclear RNAs (snRNAs). |
| transition between slow and fast fiber | The process of conversion of slow-contracting muscle fibers to a faster character. This may involve increasing of contractile rate, fast myosin gene induction, increase in glycolytic metabolic properties, altered electrophysiology and altered innervation. This process also regulates skeletal muscle adapatation. |
7 homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| A7MB80 | GTF2I | General transcription factor II-I | Bos taurus (Bovine) | PR |
| A4IFA3 | GTF2IRD2 | General transcription factor II-I repeat domain-containing protein 2 | Bos taurus (Bovine) | PR |
| P78347 | GTF2I | General transcription factor II-I | Homo sapiens (Human) | PR |
| Q9UHL9 | GTF2IRD1 | General transcription factor II-I repeat domain-containing protein 1 | Homo sapiens (Human) | PR |
| Q6EKJ0 | GTF2IRD2B | General transcription factor II-I repeat domain-containing protein 2B | Homo sapiens (Human) | PR |
| Q86UP8 | GTF2IRD2 | General transcription factor II-I repeat domain-containing protein 2A | Homo sapiens (Human) | PR |
| Q9ESZ8 | Gtf2i | General transcription factor II-I | Mus musculus (Mouse) | PR |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MALLGKHCDI | PTNGCGSERW | NSTFARKDEL | INSLVSALDS | MCSALSKLNT | EVACVAVHNE |
| 70 | 80 | 90 | 100 | 110 | 120 |
| SVFVMGTEKG | RVFLNTRKEL | QSDFLRFCRG | PLWNDPEAGH | PKKVQRCEGG | GRSLPRSSLE |
| 130 | 140 | 150 | 160 | 170 | 180 |
| QCSDVYLLQK | MVEEVFDVLY | SEAMGRATVV | PLPYERLLRE | PGLLAVQGLP | EGLAFRRPAE |
| 190 | 200 | 210 | 220 | 230 | 240 |
| YDPKALMAIL | EHSHRIRFKL | RRPPDDGGQD | TKALVEMNGI | SLLPKGSRDC | GLHGQASKVA |
| 250 | 260 | 270 | 280 | 290 | 300 |
| PQDLTPTATP | SSMANFLYST | SMPNHTIREL | KQEVPTCPLT | PSDLGMGWPV | PEPHVPSTQD |
| 310 | 320 | 330 | 340 | 350 | 360 |
| FSDCCGQTPA | GPAGPLIQNV | HASKRILFSI | VHDKSEKWDP | FIKEMEDINT | LRECVQILFN |
| 370 | 380 | 390 | 400 | 410 | 420 |
| SRYAEALGLD | HMVPVPYRKI | ACDPEAVEIV | GIPDKIPFKR | PCTYGVPKLK | RILEERHSIH |
| 430 | 440 | 450 | 460 | 470 | 480 |
| FIIKRMFDER | IFTGNKFTKD | PMKLEPASPP | EDTSTEVCRD | SMLDLAGTAW | SDMSSVSEDC |
| 490 | 500 | 510 | 520 | 530 | 540 |
| GPGTSGEIAM | LRPIKIEPEE | LDIIQVTVSD | PSPTSEEMTD | SLPGHLPSED | SGYGMEMPAD |
| 550 | 560 | 570 | 580 | 590 | 600 |
| KGPSEEPWSE | ERPAEESPGD | VIRPLRKQVE | MLFNTKYAKA | IGTSEPVKVP | YSKFLMHPEE |
| 610 | 620 | 630 | 640 | 650 | 660 |
| LFVLGLPEGI | SLRRPNCFGI | AKLRKILEAS | NSIQFVIKRP | ELLTDGVKEP | VLDTQERDSW |
| 670 | 680 | 690 | 700 | 710 | 720 |
| DRLVDETPKR | QGLQENYNTR | LSRIDIANTL | REQVQDLFNK | KYGEALGIKY | PVQVPYKRIK |
| 730 | 740 | 750 | 760 | 770 | 780 |
| SNPGSVIIEG | LPPGIPFRKP | CTFGSQNLER | ILSVADKIKF | TVTRPFQGLI | PKPETKILTT |
| 790 | 800 | 810 | 820 | 830 | 840 |
| GHEAGKTTRP | RRLQQDTWQP | DEDDANRLGE | KVILREQVKE | LFNEKYGEAL | GLNRPVLVPY |
| 850 | 860 | 870 | 880 | 890 | 900 |
| KLIRDSPDAV | EVKGLPDDIP | FRNPNTYDIH | RLEKILKARE | HVRMVIINQL | QPFAEVCNDP |
| 910 | 920 | 930 | 940 | 950 | 960 |
| KVPEEDDSNK | LGKKVILREQ | VKELFNEKYG | EALGLNRPVL | VPYKLIRDSP | DAVEVKGLPD |
| 970 | 980 | 990 | 1000 | 1010 | 1020 |
| DIPFRNPNTY | DIHRLEKILK | AREHVRMVII | NQLQPFGDVC | NNAKVPAKDN | IPKRKRKRVS |
| 1030 | 1040 | 1050 | 1060 | 1070 | 1080 |
| EGNSVSSSSS | SSSSSSNPES | VASTNQISLV | VKSRGSELHP | NSVWPLPLPR | AGPSTAPGTG |
| 1090 | 1100 | ||||
| RHWALRGTQP | TTEGQAHPLV | LPTR |